{{Rsnum
|rsid=4984
|Gene=ADD2
|Chromosome=2
|position=70673271
|Orientation=plus
|GMAF=0.1198
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ADD2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 76.9 | 23.1 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 72.6 | 25.8 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{omim
|desc=ADDUCIN 2; ADD2
|id=102681
|rsnum=4984
}}

{{PMID Auto
|PMID=19838659
|Title=alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy
|OA=1
}}

{{PMID|17854487|OA=1
}} Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension.

{{PMID|18787518}} Arterial properties in relation to genetic variations in the adducin subunits in a white population.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}